Poliomyelitis

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Epidemics of paralytic poliomyelitis occurred regularly before the introduction of polio vaccination. Such epidemics are most problematic in the developed world. In undeveloped countries, cases are generally sporadic with few epidemics. This difference is largely the result of public health practices in the developed world. In undeveloped countries, polio is transmitted via contaminated drinking water and typically infected infants at a young age. The post-polio syndrome, which includes progressive fatigue, pain, and weakness, is present late in life in a majority of survivors of paralytic poliomyelitis. Although it is a common diagnosis, the epidemiological studies suggest that the rate of decline is modest in the majority of patients and carries a benign prognosis in most. The pathophysiology of the post-polio syndrome remains debated, but leading theories include dying-back of axonal sprouts in massively reinnervated motor units, attritional loss of affected anterior horn cells and physiological aging on a fixed neurological deficit. Treatment of the post-polio syndrome is limited to symptomatic care. Fatigue is unresponsive to multiple medication trials and responds best to energy conservation. Pain requires a thorough evaluation with treatment directed at specific etiologies. Most patients can expect years of neuromuscular stability and only a minority requires additional lifestyle modifications later in life.

Original languageEnglish (US)
Title of host publicationNeurobiology of Disease
PublisherElsevier Inc.
Pages545-551
Number of pages7
ISBN (Print)9780120885923
DOIs
StatePublished - 2007

Fingerprint

Postpoliomyelitis Syndrome
Poliomyelitis
Fatigue
Anterior Horn Cells
Public Health Practice
Pain
Cell Aging
Drinking Water
Survivors
Life Style
Epidemiologic Studies
Vaccination
Therapeutics

ASJC Scopus subject areas

  • Dentistry(all)
  • Medicine(all)

Cite this

Sorenson, E. J. (2007). Poliomyelitis. In Neurobiology of Disease (pp. 545-551). Elsevier Inc.. https://doi.org/10.1016/B978-012088592-3/50050-5

Poliomyelitis. / Sorenson, Eric J.

Neurobiology of Disease. Elsevier Inc., 2007. p. 545-551.

Research output: Chapter in Book/Report/Conference proceedingChapter

Sorenson, EJ 2007, Poliomyelitis. in Neurobiology of Disease. Elsevier Inc., pp. 545-551. https://doi.org/10.1016/B978-012088592-3/50050-5
Sorenson EJ. Poliomyelitis. In Neurobiology of Disease. Elsevier Inc. 2007. p. 545-551 https://doi.org/10.1016/B978-012088592-3/50050-5
Sorenson, Eric J. / Poliomyelitis. Neurobiology of Disease. Elsevier Inc., 2007. pp. 545-551
@inbook{4f3c9aeb476c4724b2cd2ef1e33495b8,
title = "Poliomyelitis",
abstract = "Epidemics of paralytic poliomyelitis occurred regularly before the introduction of polio vaccination. Such epidemics are most problematic in the developed world. In undeveloped countries, cases are generally sporadic with few epidemics. This difference is largely the result of public health practices in the developed world. In undeveloped countries, polio is transmitted via contaminated drinking water and typically infected infants at a young age. The post-polio syndrome, which includes progressive fatigue, pain, and weakness, is present late in life in a majority of survivors of paralytic poliomyelitis. Although it is a common diagnosis, the epidemiological studies suggest that the rate of decline is modest in the majority of patients and carries a benign prognosis in most. The pathophysiology of the post-polio syndrome remains debated, but leading theories include dying-back of axonal sprouts in massively reinnervated motor units, attritional loss of affected anterior horn cells and physiological aging on a fixed neurological deficit. Treatment of the post-polio syndrome is limited to symptomatic care. Fatigue is unresponsive to multiple medication trials and responds best to energy conservation. Pain requires a thorough evaluation with treatment directed at specific etiologies. Most patients can expect years of neuromuscular stability and only a minority requires additional lifestyle modifications later in life.",
author = "Sorenson, {Eric J.}",
year = "2007",
doi = "10.1016/B978-012088592-3/50050-5",
language = "English (US)",
isbn = "9780120885923",
pages = "545--551",
booktitle = "Neurobiology of Disease",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Poliomyelitis

AU - Sorenson, Eric J.

PY - 2007

Y1 - 2007

N2 - Epidemics of paralytic poliomyelitis occurred regularly before the introduction of polio vaccination. Such epidemics are most problematic in the developed world. In undeveloped countries, cases are generally sporadic with few epidemics. This difference is largely the result of public health practices in the developed world. In undeveloped countries, polio is transmitted via contaminated drinking water and typically infected infants at a young age. The post-polio syndrome, which includes progressive fatigue, pain, and weakness, is present late in life in a majority of survivors of paralytic poliomyelitis. Although it is a common diagnosis, the epidemiological studies suggest that the rate of decline is modest in the majority of patients and carries a benign prognosis in most. The pathophysiology of the post-polio syndrome remains debated, but leading theories include dying-back of axonal sprouts in massively reinnervated motor units, attritional loss of affected anterior horn cells and physiological aging on a fixed neurological deficit. Treatment of the post-polio syndrome is limited to symptomatic care. Fatigue is unresponsive to multiple medication trials and responds best to energy conservation. Pain requires a thorough evaluation with treatment directed at specific etiologies. Most patients can expect years of neuromuscular stability and only a minority requires additional lifestyle modifications later in life.

AB - Epidemics of paralytic poliomyelitis occurred regularly before the introduction of polio vaccination. Such epidemics are most problematic in the developed world. In undeveloped countries, cases are generally sporadic with few epidemics. This difference is largely the result of public health practices in the developed world. In undeveloped countries, polio is transmitted via contaminated drinking water and typically infected infants at a young age. The post-polio syndrome, which includes progressive fatigue, pain, and weakness, is present late in life in a majority of survivors of paralytic poliomyelitis. Although it is a common diagnosis, the epidemiological studies suggest that the rate of decline is modest in the majority of patients and carries a benign prognosis in most. The pathophysiology of the post-polio syndrome remains debated, but leading theories include dying-back of axonal sprouts in massively reinnervated motor units, attritional loss of affected anterior horn cells and physiological aging on a fixed neurological deficit. Treatment of the post-polio syndrome is limited to symptomatic care. Fatigue is unresponsive to multiple medication trials and responds best to energy conservation. Pain requires a thorough evaluation with treatment directed at specific etiologies. Most patients can expect years of neuromuscular stability and only a minority requires additional lifestyle modifications later in life.

UR - http://www.scopus.com/inward/record.url?scp=84884011836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884011836&partnerID=8YFLogxK

U2 - 10.1016/B978-012088592-3/50050-5

DO - 10.1016/B978-012088592-3/50050-5

M3 - Chapter

AN - SCOPUS:84884011836

SN - 9780120885923

SP - 545

EP - 551

BT - Neurobiology of Disease

PB - Elsevier Inc.

ER -